NCT07283120

Brief Summary

The investigators aim to document the surgery-specific and overall Quality of life parameters of patients undergoing all types of breast surgery at the University Hospital of Basel

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
111mo left

Started May 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
May 2025Jun 2035

Study Start

First participant enrolled

May 16, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 15, 2025

Completed
9.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2035

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2035

Last Updated

December 15, 2025

Status Verified

December 1, 2025

Enrollment Period

10.1 years

First QC Date

December 2, 2025

Last Update Submit

December 2, 2025

Conditions

Breast Surgery

Outcome Measures

Primary Outcomes (2)

  • Patient satisfaction

    five point likert-scale for satisfaction ( psychometric survey response scale ranging from "Strongly Disagree" to "Strongly Agree". The format includes: 1. Strongly Disagree, 2. Disagree, 3. Neutral (or Neither Agree nor Disagree), 4. Agree, and 5. Strongly Agree Descriptive measures using patient-reported outcome measures (BREAST-Q, McGill short form, EQ-5D-5L)

    up to 10 years

  • Patient reported quality of life

    Descriptive measures using patient-reported outcome measures (BREAST-Q, McGill short form, EQ-5D-5L)

    up to 10 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients who underwent breast surgery at the University Hospital Basel from 2014 onwards

You may qualify if:

  • adults who underwent any type of breast surgery at the University Hospital of Basel

You may not qualify if:

  • Patients under the age of 18 years, without general consent or written informed consent, with insufficient language comprehension or other factors limiting their ability to co-operate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Basel

Basel, 4031, Switzerland

RECRUITING

Study Officials

  • Elisabeth Kappos, Prof.

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elisabeth Kappos, Prof.

CONTACT

+4161 265 25 25elisabeth.kappos@usb.ch

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2025

First Posted

December 15, 2025

Study Start

May 16, 2025

Primary Completion (Estimated)

June 30, 2035

Study Completion (Estimated)

June 30, 2035

Last Updated

December 15, 2025

Record last verified: 2025-12

Locations

CH(1)